American Century Companies’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-69,479
| Closed | -$1M | – | 2933 |
|
|
2026
Q1 | $1M | Buy |
69,479
+34,489
| +99% | +$494K | ﹤0.01% | 2328 |
|
|
2025
Q4 | $498K | Buy |
+34,990
| New | +$344K | ﹤0.01% | 2519 |
|
|
2025
Q2 | – | Sell |
-3,899,228
| Closed | -$31.8M | – | 2886 |
|
|
2025
Q1 | $31.8M | Sell |
3,899,228
-3,204
| -0.1% | -$29.6K | 0.02% | 820 |
|
|
2024
Q4 | $36.8M | Sell |
3,902,432
-2,225
| -0.1% | -$23.1K | 0.02% | 757 |
|
|
2024
Q3 | $41.7M | Sell |
3,904,657
-18,808
| -0.5% | -$205K | 0.02% | 683 |
|
|
2024
Q2 | $38.9M | Sell |
3,923,465
-877,434
| -18% | -$9.01M | 0.02% | 673 |
|
|
2024
Q1 | $56.6M | Buy |
4,800,899
+218,832
| +5% | +$2.8M | 0.04% | 502 |
|
|
2023
Q4 | $65M | Buy |
4,582,067
+238,197
| +5% | +$2.7M | 0.04% | 421 |
|
|
2023
Q3 | $52.8M | Buy |
4,343,870
+429,257
| +11% | +$5.54M | 0.04% | 443 |
|
|
2023
Q2 | $49.2M | Buy |
+3,914,613
| New | +$46.5M | 0.04% | 438 |
|
|
2022
Q3 | – | Sell |
-49,340
| Closed | -$530K | – | 2452 |
|
|
2022
Q2 | $530K | Buy |
+49,340
| New | +$406K | ﹤0.01% | 1902 |
|
|
2021
Q1 | – | Sell |
-807,412
| Closed | -$18.6M | – | 2212 |
|
|
2020
Q4 | $18.6M | Sell |
807,412
-905
| -0.1% | -$18.5K | 0.01% | 632 |
|
|
2020
Q3 | $11.4M | Sell |
808,317
-76,469
| -9% | -$1.11M | 0.01% | 683 |
|
|
2020
Q2 | $13.3M | Buy |
884,786
+237,015
| +37% | +$2.89M | 0.01% | 606 |
|
|
2020
Q1 | $5.99M | Sell |
647,771
-39,389
| -6% | -$374K | 0.01% | 702 |
|
|
2019
Q4 | $6.69M | Buy |
687,160
+235,788
| +52% | +$2.16M | 0.01% | 763 |
|
|
2019
Q3 | $3.62M | Buy |
451,372
+26,657
| +6% | +$289K | ﹤0.01% | 868 |
|
|
2019
Q2 | $5.3M | Buy |
424,715
+78,240
| +23% | +$993K | 0.01% | 821 |
|
|
2019
Q1 | $4.71M | Sell |
346,475
-7,620
| -2% | -$93.1K | ﹤0.01% | 832 |
|
|
2018
Q4 | $3.39M | Sell |
354,095
-311,796
| -47% | -$3.43M | ﹤0.01% | 886 |
|
|
2018
Q3 | $8.05M | Buy |
665,891
+64,743
| +11% | +$905K | 0.01% | 715 |
|
|
2018
Q2 | $9.39M | Buy |
601,148
+361,762
| +151% | +$5.47M | 0.01% | 665 |
|
|
2018
Q1 | $3.6M | Buy |
239,386
+139,179
| +139% | +$2.12M | ﹤0.01% | 904 |
|
|
2017
Q4 | $1.44M | Buy |
100,207
+13,879
| +16% | +$191K | ﹤0.01% | 1056 |
|
|
2017
Q3 | $1.3M | Buy |
+86,328
| New | +$1.14M | ﹤0.01% | 1104 |
|
|
2016
Q2 | – | Sell |
-124,016
| Closed | -$1.05M | – | 1350 |
|
|
2016
Q1 | $1.05M | Buy |
+124,016
| New | +$878K | ﹤0.01% | 1092 |
|
Other funds holding FOLD
American Century Companies's FOLD Position: Q2 2026 in Review
American Century Companies sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 69,479 shares — an estimated $1M sold.
American Century Companies first reported a position in FOLD in Q1 2016 and held it in 26 quarters. The position peaked at $65M in Q4 2023. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- American Century Companies reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- American Century Companies sold 69,479 Amicus Therapeutics shares in Q2 2026, an estimated $1M.
- American Century Companies first reported a position in Amicus Therapeutics in Q1 2016 and held it in 26 quarters.
- American Century Companies's Amicus Therapeutics position peaked at $65M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.